Journal of Pharmaceutical and Biomedical Sciences

Outcome of Vitamin D Supplementation on Implant Osseointegration in Patients Suffering from Chronic Kidney Disease: A Prospective Randomized Study

YashPaul Dev Sharma, Preetinder Singh, Raghav Yashbir, Kaur Manvir, Sharma Shivli, Wahi Ankur

Abstract


Aim This study was aimed to investigate the effect of Vit D supplementation on implant osseointegration in CKD.
Settings and Design This was a prospective randomized study conducted on 20 patients with complaint of missing teeth and who had chronic kidney disease. After evaluation of the medical reports of the patients; medical consultancy was taken from the physician.

Materials and Methods Out of twenty patients ten were given vitamin D supplements (60,000 IU). Implants were placed under aseptic conditions. The following radiographic and clinical parameters were evaluated-1) Height of crestal bone. 2) Implant mobility. 3) Papilla fill index. 4) bleeding on probing.
Statistical Analysis Used The results were compiled and statistically analyzed using SPSS Version 19 Version. The Mann–Whitney U Test was used for the intergroup comparison and Wilcoxon Sign Rank Test for the intra-group comparison.

Results Statistically, significant results were seen in Group I, which were on vitamin D supplementation in relation to osseointegration when compared to group II. It demonstrated that weekly supplementation with 60,000 IU of cholecalciferol for 12 weeks is an effective way of correcting vitamin D status in patients with CKD stage 3 and 4 which also, helps in the formation of bone for osseointegration.

Conclusion Implants placed in patients with CKD on vitamin D supplementation were more successfully osseointegrated and functional, which was confirmed clinically and radiographically.


Keywords


dental implants; chronic kidney diseases; bone mineralization; osseointegration; parathyroid hormone (PTH)

Full Text:

References


Marakoglu I, Gursoy UK, Demirer S, Sezer H. Periodontal status of chronic renal failure patients receiving hemodialysis. Yonsei Med J. 2003;44(4):648–52.

Brasil. Ministério da Saúde. Painel de Indicadores do SUS Nº7. Departamento de Monitoramento e Avaliação do SUS/ Secretaria de Gestão Estratégica e Participativa. Brasília, DF; 2010.

Gonçalves EM, Karam LALL, Milfont TS, Araújo MD, Santana JML, Lima DLF. Prevalência de periodontite em pacientes submetidos a hemodiálise. J Bras Nefrol. 2007;29(3):115–9.

Pelletier S, Chapurlat R. Optimizing bone health in chronic kidney disease. Maturitas. 2010;65:325–33.

Ott SM. Bone disease in CKD. Curr Opin Nephrol Hypertens. 2012;21:376–81.

Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Kidney Disease: Improving Global Outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;69:1945–53.

KDIGO. Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;S1–S130.

Lee MM, Chu EY, El-Abbadi MM, Foster BL, Tompkins KA, Giachelli CM, Somerman MJ. Characterization of mandibular bone in a mouse model of chronic kidney disease. J Periodontol.2010; 81:300–9.

Craig RG, Kotanko P, Kamer AR, Levin NW. Periodontal diseases–a modifiable source of systemic inflammation for the end-stage renal disease patient on haemodialysis therapy? Nephrol Dial Transplant. 2007; 22:312–5.

Stellingsma C, Vissink A, Meijer HJ, Kuiper C, Raghoebar GM. Implantology and the severely resorbed edentulous mandible. Crit Rev Oral Biol Med. 2004;15:240–8.

Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, et al. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25- hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int. 1999;55: 1019–27.

González EA, Sachdeva A, Oliver DA, Martin KJ. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. American journal of nephrology. 2004;24:503–10.

Rouached M, El Kadiri Boutchich S, Al Rifai AM, Garabedian M, Fournier A. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2008;74:389–90.

Chandra P, Binongo JN, Ziegler TR, Schlanger LE, Wang W, Someren JT, et al. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract. 2008;14:10–17.

LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis.2005;45:1026–33.

Brinker MR, O’Connor DP, Monla YT, Earthman TP. Metabolic and endocrine abnormalities in patients with nonunions. J Orthop Trauma. 2007;21:557–70.

Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92:4–8.

Bergwitz C, Jüppner H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med. 2010;61:91–104.

Andress DL. Adynamic bone in patients with chronic kidney disease. Kidney Int. 2008;73:1345–54.

Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81.

Nickolas TL, Stein E, Cohen A, Thomas V, Staron RB, Donald J, et al. Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol. 2010;21:1371–80.

Kelly J, Lin A, Wang CJ, Park S, Nishimura I. Vitamin D and bone physiology: demonstration of vitamin D deficiency in an implant osseointegration rat model. J Prosthodont. 2009;18:473–78.

Alvim-Pereira F, Montes CC, Thomé G, Olandoski M, Trevilatto PC. Analysis of association of clinical aspects and vitamin D receptor gene polymorphism with dental implant loss. Clin Oral Implants Res. 2008;19:786–95.

Jingushi S, Iwaki A, Higuchi O, Azuma Y, Ohta T, Shida JI, et al. Serum 1alpha,25-dihydroxyvitamin D3 accumulates into the fracture callus during rat femoral fracture healing. Endocrinology.139:1467–73.

Xu B, Zhang J, Brewer E, Tu Q, Yu L, Tang J, et al. Osterix enhances BMSC associated osseointegration of implants. J Dent Res. 2009;88:1003–07.

Mombelli A, van Oosten MAC, Schu¨r ch E, Lang NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol. 1987;2:145–15.

Wasserman BH, Geiger AM, Turgeon LR. Relationship of occlusion and periodontal disease: VII. Mobility. J Periodontol. 1973;44:572–78.

Jemt T. Regeneration of papillae after single-implant treatment. Int J Periodontics Restorative Dent. 1997;17:327–33.

Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, et al. Increased risk of hip fracture among patients with endstage renal disease. Kidney Int. 2000;58:396–99.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.